Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Evolus, Inc. EOLS |
TANG CAPITAL MANAGEMENT, LLC | 4,847,399 7.700% |
4,847,399 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL MANAGEMENT, LLC | 4,321,547 9.990% |
4,321,547 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Precision BioSciences, Inc. DTIL |
TANG CAPITAL MANAGEMENT, LLC | 623,332 8.600% |
623,332 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Adicet Bio, Inc. ACET |
TANG CAPITAL MANAGEMENT, LLC | 8,216,960 9.970% |
8,216,960 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | AnaptysBio, Inc. ANAB |
TANG CAPITAL MANAGEMENT, LLC | 1,330,879 4.400% |
1,330,879 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | BioAtla, Inc. BCAB |
TANG CAPITAL MANAGEMENT, LLC | 874,076 1.800% |
874,076 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
TANG CAPITAL MANAGEMENT, LLC | 600,000 4.980% |
600,000 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | LENZ Therapeutics, Inc. LENZ |
TANG CAPITAL MANAGEMENT, LLC | 766,940 2.800% |
766,940 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR |
TANG CAPITAL MANAGEMENT, LLC | 294,626 2.300% |
294,626 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Unchanged |
2024-09-30 | 13G | Quince Therapeutics, Inc. QNCX |
TANG CAPITAL MANAGEMENT, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-08 4:56 pm Purchase |
2024-11-01 | 13D | ESSA Pharma Inc. EPIX |
TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% |
4,300,000 (New Position) |
Filing History |
| 2024-10-24 4:08 pm Purchase |
2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR |
TANG CAPITAL MANAGEMENT, LLC | 200,000 5.100% |
200,000 (New Position) |
Filing History |
| 2024-10-08 4:20 pm Purchase |
2024-10-01 | 13D | Kezar Life Sciences, Inc. KZR |
TANG CAPITAL MANAGEMENT, LLC | 720,000 9.900% |
720,000 (New Position) |
Filing History |
| 2024-09-30 09:00 am Purchase |
2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT, LLC | 2,407,800 6.600% |
2,407,800 (New Position) |
Filing History |
| 2024-09-18 4:26 pm Purchase |
2024-09-16 | 13D | Singular Genomics Systems, Inc. OMIC |
TANG CAPITAL MANAGEMENT, LLC | 372,000 14.900% |
372,000 (New Position) |
Filing History |
| 2024-09-12 4:10 pm Purchase |
2024-09-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT, LLC | 7,229,500 5.100% |
7,229,500 (New Position) |
Filing History |
| 2022-04-21 4:00 pm Purchase |
2022-04-11 | 13G | Inspirato Incorporated ISPO |
TANG CAPITAL MANAGEMENT, LLC | 121,630 5.000% |
121,630 (New Position) |
Filing History |
| 2022-04-21 4:00 pm Purchase |
2022-04-11 | 13G | ASLAN Pharmaceuticals Limited ASLN |
TANG CAPITAL MANAGEMENT, LLC | 469,903 5.400% |
469,903 (New Position) |
Filing History |